These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37041730)

  • 1. IgM anti-MAG
    Hamadeh T; van Doormaal PTC; Pruppers MHJ; van de Mortel JPM; Hoeijmakers JGJ; Cornblath DR; Vrancken AFJE; Faber CG; Notermans NC; Merkies ISJ;
    J Peripher Nerv Syst; 2023 Jun; 28(2):269-275. PubMed ID: 37041730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.
    Lunn MP; Nobile-Orazio E
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD002827. PubMed ID: 27701752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuropathies associated with monoclonal IgM anti-MAG antibodies].
    Pihan M; Decaux O; Marcorelles P; Bahon-Riedinger I; Lemercier S; Gainche-Salmon A; Doncker AV
    Rev Med Interne; 2012 Dec; 33(12):686-92. PubMed ID: 22726239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of anti-HNK1 antibodies in the management of anti-MAG neuropathies.
    Delmont E; Attarian S; Antoine JC; Paul S; Camdessanché JP; Grapperon AM; Brodovich A; Boucraut J
    J Neurol; 2019 Aug; 266(8):1973-1979. PubMed ID: 31089861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-sulfatide/galactocerebroside antibodies in immunoglobulin M paraproteinemic neuropathies.
    Boso F; Ruggero S; Giannotta C; Benedetti L; Marfia GA; Ermani M; Campagnolo M; Salvalaggio A; Gallia F; De Michelis C; Visentin A; Bianco M; Ruiz M; Mataluni G; Nobile-Orazio E; Briani C
    Eur J Neurol; 2017 Nov; 24(11):1334-1340. PubMed ID: 28782863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum neurofilament light chain, contactin-1 and complement activation in anti-MAG IgM paraprotein-related peripheral neuropathy.
    Amaador K; Wieske L; Koel-Simmelink MJA; Kamp A; Jongerius I; de Heer K; Teunissen CE; Minnema MC; Notermans NC; Eftimov F; Kersten MJ; Vos JMI
    J Neurol; 2022 Jul; 269(7):3700-3705. PubMed ID: 35157138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Native versus deglycosylated IgM in anti-MAG neuropathy: Correlation with clinical status - Study of 10 cases.
    Neil J; Choumet V; Beadon K; Delmont E; Ghillani P; Boucraut J; Musset L; Léger JM
    J Neuroimmunol; 2020 Feb; 339():577094. PubMed ID: 31756640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revisiting the spectrum of IgM-related neuropathies in a large cohort of IgM monoclonal gammopathy.
    Bardel B; Molinier-Frenkel V; Le Bras F; Ayache SS; Nordine T; Lefaucheur JP; Planté-Bordeneuve V
    J Neurol; 2022 Sep; 269(9):4955-4960. PubMed ID: 35505107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and laboratory features of anti-MAG neuropathy without monoclonal gammopathy.
    Pascual-Goñi E; Martín-Aguilar L; Lleixà C; Martínez-Martínez L; Simón-Talero MJ; Díaz-Manera J; Cortés-Vicente E; Rojas-García R; Moga E; Juárez C; Illa I; Querol L
    Sci Rep; 2019 Apr; 9(1):6155. PubMed ID: 30992531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic value of autoantibodies to MAG by ELISA Bühlmann in 117 immune-mediated peripheral neuropathies associated with monoclonal IgM to SGPG/SGLPG].
    Caudie C; Kaygisiz F; Jaquet P; Petiot P; Gonnaud PM; Antoine JC; Vial C
    Ann Biol Clin (Paris); 2006; 64(4):353-9. PubMed ID: 16829480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical phenotype of patients with neuropathy associated with monoclonal gammopathy: a comparative study and a review of the literature.
    Stork AC; van der Pol WL; Franssen H; Jacobs BC; Notermans NC
    J Neurol; 2014 Jul; 261(7):1398-404. PubMed ID: 24781837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.
    Lunn MP; Nobile-Orazio E
    Cochrane Database Syst Rev; 2012 May; (5):CD002827. PubMed ID: 22592686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-myelin-associated glycoprotein neuropathy: Where do we stand?
    Stino AM; Elsheikh B; Allen JA
    Muscle Nerve; 2023 Nov; 68(6):823-832. PubMed ID: 37602932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy for IgM anti-Myelin-Associated Glycoprotein paraprotein-associated peripheral neuropathies.
    Lunn MP; Nobile-Orazio E
    Cochrane Database Syst Rev; 2003; (1):CD002827. PubMed ID: 12535440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.
    Lunn MP; Nobile-Orazio E
    Cochrane Database Syst Rev; 2006 Apr; (2):CD002827. PubMed ID: 16625561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of anti-MAG IgM autoantibody binding to myelin by an antigen-specific glycopolymer.
    Aliu B; Demeestere D; Seydoux E; Boucraut J; Delmont E; Brodovitch A; Oberholzer T; Attarian S; Théaudin M; Tsouni P; Kuntzer T; Derfuss T; Steck AJ; Ernst B; Herrendorff R; Hänggi P
    J Neurochem; 2020 Sep; 154(5):486-501. PubMed ID: 32270492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation and Management of Immunoglobulin M- and Waldenström-Associated Peripheral Neuropathies.
    Tomkins O; Leblond V; Lunn MP; Viala K; Weil DR; D'Sa S
    Hematol Oncol Clin North Am; 2023 Aug; 37(4):761-776. PubMed ID: 37385714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational Profile in 75 Patients With Anti-Myelin-Associated Glycoprotein Neuropathy: Clinical and Hematologic Therapy Response and Hints on New Therapeutic Targets.
    Castellani F; Visentin A; Schirinzi E; Salvalaggio A; Cacciavillani M; Candiotto C; Baratè C; Cellini A; Bertorelle R; Siciliano G; Trentin L; Briani C
    Neurol Neuroimmunol Neuroinflamm; 2023 Jul; 10(4):. PubMed ID: 37137530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to myelin-associated glycoprotein (anti-Mag) in IgM amyloidosis may influence expression of neuropathy in rare patients.
    Garces-Sanchez M; Dyck PJ; Kyle RA; Zeldenrust S; Wu Y; Ladha SS; Klein CJ
    Muscle Nerve; 2008 Apr; 37(4):490-5. PubMed ID: 18236455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autocrine TNF-α Increases Penetration of Myelin-Associated Glycoprotein Antibodies Across the Blood-Nerve Barrier in Anti-MAG Neuropathy.
    Sato R; Shimizu F; Kuwahara M; Mizukami Y; Watanabe K; Maeda T; Sano Y; Takeshita Y; Koga M; Kusunoki S; Kanda T
    Neurol Neuroimmunol Neuroinflamm; 2023 May; 10(3):. PubMed ID: 36810162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.